About Ash Mansour

This author has not yet filled in any details.
So far Ash Mansour has created 27 blog entries.

The blood test that detects killer SEPSIS in five minutes

Revolutionary treatment could save thousands of lives, and may soon be introduced in the NHS Sepsis is a life-threatening condition caused by your own body's immune system It occurs when your body overreacts to any infection, even to a small cut or bite The new test has the potential to save hundreds of

Press release: Biomedical screening devices soon in your pharmacy

PRESS RELEASE: BIOMEDICAL SCREENING DEVICES SOON IN YOUR PHARMACY Source: Abionic.com Biomedical screening devices soon in your pharmacy Lausanne, Switzerland, May 11, 2016 - Starting in November, the AbioSCOPE, a biomedical screening device, in particular for allergies and iron deficiency, will progressively be available in pharmacies in Switzerland. Abionic, the company which developed

VR Startup MindMaze Raises Funds at $1.1 Billion Valuation

VR STARTUP MINDMAZE RAISES FUNDS AT $1.1 BILLION VALUATION Source: bloomberg.com MindMaze SA, a Swiss virtual reality startup, said it raised a round of financing that values the company at $1.1 billion. The startup picked up $100 million in the round led by Hinduja Group India Ltd., an Indian conglomerate. MindMaze makes an

MindMaze in TedMed

MindMaze in TedMed A spinoff from the Swiss Federal Institute of Technology, MindMaze combines virtual reality with state-of-the-art brain imaging technologies to help people with traumatic brain injury transcend disability and live more complete and satisfying lives. “Coming from an engineering background, it made a strong impression when I came across the standard

Abionic has been ranked 2nd best Swiss Startup in 2015

Abionic has been ranked 2nd best Swiss Startup in 2015 A revolution with regulatory approval. The system of Abionic for meaningful allergy tests in doctor’s offices and pharmacies shakes up a market worth billions in revenue. Source: venturelab.ch – 13 october 2015 Abionic has been located in the EPFL Innovation Park in Lausanne

Go to Top